hydroxychloroquine has been researched along with Co-infection in 10 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mucormycosis is an invasive fungal infection (IFI) due to several species of saprophytic fungi, occurring in patients with underlying co-morbidities (including organ transplantation)." | 1.62 | Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature. ( Berlinrut, I; Chang, KM; Khatri, A; Wallach, F, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khaddour, K | 1 |
| Sikora, A | 1 |
| Tahir, N | 1 |
| Nepomuceno, D | 1 |
| Huang, T | 1 |
| Tadolini, M | 1 |
| Codecasa, LR | 1 |
| García-García, JM | 1 |
| Blanc, FX | 1 |
| Borisov, S | 1 |
| Alffenaar, JW | 1 |
| Andréjak, C | 1 |
| Bachez, P | 1 |
| Bart, PA | 1 |
| Belilovski, E | 1 |
| Cardoso-Landivar, J | 1 |
| Centis, R | 1 |
| D'Ambrosio, L | 1 |
| Luiza De Souza-Galvão, M | 1 |
| Dominguez-Castellano, A | 1 |
| Dourmane, S | 1 |
| Fréchet Jachym, M | 1 |
| Froissart, A | 1 |
| Giacomet, V | 1 |
| Goletti, D | 1 |
| Grard, S | 1 |
| Gualano, G | 1 |
| Izadifar, A | 1 |
| Le Du, D | 1 |
| Marín Royo, M | 1 |
| Mazza-Stalder, J | 1 |
| Motta, I | 1 |
| Ong, CWM | 1 |
| Palmieri, F | 1 |
| Rivière, F | 1 |
| Rodrigo, T | 1 |
| Silva, DR | 1 |
| Sánchez-Montalvá, A | 1 |
| Saporiti, M | 1 |
| Scarpellini, P | 1 |
| Schlemmer, F | 1 |
| Spanevello, A | 1 |
| Sumarokova, E | 1 |
| Tabernero, E | 1 |
| Tambyah, PA | 1 |
| Tiberi, S | 1 |
| Torre, A | 1 |
| Visca, D | 1 |
| Zabaleta Murguiondo, M | 1 |
| Sotgiu, G | 1 |
| Migliori, GB | 1 |
| Chen, FL | 1 |
| Wang, CH | 1 |
| Hung, CS | 1 |
| Su, YS | 1 |
| Lee, WS | 1 |
| Molina-Iturritza, E | 1 |
| San-José-Muñiz, I | 1 |
| Ganchegui-Aguirre, M | 1 |
| Balerdi-Sarasola, L | 1 |
| Ortiz-de-Zárate-Ibarra, Z | 1 |
| Gainzarain-Arana, JC | 1 |
| Portu-Zapirain, J | 1 |
| Regazzoni, V | 1 |
| Loffi, M | 1 |
| Garini, A | 1 |
| Danzi, GB | 1 |
| Rivas, N | 1 |
| Espinoza, M | 1 |
| Loban, A | 1 |
| Luque, O | 1 |
| Jurado, J | 1 |
| Henry-Hurtado, N | 1 |
| Goodridge, A | 1 |
| Kumar, G | 1 |
| Adams, A | 1 |
| Hererra, M | 1 |
| Rojas, ER | 1 |
| Singh, V | 1 |
| Sakhuja, A | 1 |
| Meersman, M | 1 |
| Dalton, D | 1 |
| Kethireddy, S | 1 |
| Nanchal, R | 1 |
| Guddati, AK | 1 |
| Matangila, JR | 1 |
| Nyembu, RK | 1 |
| Telo, GM | 1 |
| Ngoy, CD | 1 |
| Sakobo, TM | 1 |
| Massolo, JM | 1 |
| Muyembe, BM | 1 |
| Mvwala, RK | 1 |
| Ilunga, CK | 1 |
| Limbole, EB | 1 |
| Ntalaja, JM | 1 |
| Kongo, RM | 1 |
| Anton-Vazquez, V | 1 |
| Clivillé, R | 1 |
| Khatri, A | 1 |
| Chang, KM | 1 |
| Berlinrut, I | 1 |
| Wallach, F | 1 |
10 other studies available for hydroxychloroquine and Co-infection
| Article | Year |
|---|---|
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.
Topics: Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Chicago; Chronic Pain | 2020 |
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.
Topics: Adult; Aged; Antitubercular Agents; Antiviral Agents; Azithromycin; Betacoronavirus; Clinical Labora | 2020 |
Co-infection with an atypical pathogen of COVID-19 in a young.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Azithromycin; Coinfection; COVID-19 Drug Treatment; | 2021 |
Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
Topics: Adult; Aged; Anti-Retroviral Agents; Antiviral Agents; Betacoronavirus; CD4 Lymphocyte Count; Coinfe | 2020 |
Glucocorticoid-Induced Bacterial Endocarditis in COVID-19 Pneumonia - Something to Be Concerned About?
Topics: Aged; Anti-Bacterial Agents; Betacoronavirus; Coinfection; Coronavirus Infections; COVID-19; COVID-1 | 2020 |
Case Report: COVID-19 Recovery from Triple Infection with
Topics: Adult; Antitubercular Agents; Antiviral Agents; Betacoronavirus; Coinfection; Convalescence; Coronav | 2020 |
Predictors and outcomes of healthcare-associated infections in COVID-19 patients.
Topics: Aged; Antibodies, Monoclonal, Humanized; Coinfection; COVID-19; COVID-19 Drug Treatment; Cross Infec | 2021 |
Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
Topics: Adult; Aged; Blood Coagulation; Chloroquine; Coinfection; Comorbidity; Cough; COVID-19; COVID-19 Dru | 2020 |
Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
Topics: Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Alanine; Anti-Bacterial Agents; Anti-Inflam | 2021 |
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
Topics: Aged; Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Coinfection; Combined Modality | 2021 |